The Unapproved Cure

A photograph leaked from a private clinic in Eastern Europe, a few unlabeled pale blue capsules, and a self-recorded video of someone overcoming addiction. They seep across borders like water, from Europe to North America, from the grassroots to the highest decision-making rooms. Katya Novak just wanted to save her son. A Polish woman who had worked in a slaughterhouse for half her life used the simplest methods—taking trains, carrying pill bottles, knocking on strangers' doors—to deliver a drug that supposedly could 'eradicate addiction' to those crushed by new synthetic drugs. She didn't know that the medicine in her hands was forcing regulators across the ocean to answer a question: when a life-saving drug without official approval suddenly appears, do you block it or not? Francis Harris was ordered to block it. His brother had collapsed in a bathroom in some city, with injection marks still on his arm. He knew better than anyone what those pale blue capsules meant—hope, or a trap. And eight thousand kilometers away, the young man who developed this drug, Lin Shen, had only eight team members, one laboratory, and a WHO pilot approval. He initially just wanted to publish a paper. Until he realized that his graduation project was beginning to shake an old set of rules. They thought the drug was meant to save people. They didn't expect that what saves people can sometimes be more dangerous than weapons. — Description from novelcodex.org